Revisions in the International System for Staging Lung Cancer

REFERENCES
1. Gospodarowicz MK, O’Sullivan B, Sobin LH. Prognostic Factors in
Cancer . 3rd Ed. New Jersey: Wiley-Liss, 2006.
2. Brundage MD, Mackillop WJ. Lung cancer. In: Gospodarowicz MK,
O’Sullivan B, Sobin LH, eds. Prognostic Factors in Cancer . 3rd Ed. New
Jersey: Wiley-Liss, 2006:159–163.
3. Sculier JP, Chansky K, Crowley JJ, et al. The impact of additional
prognostic factors on survival and their relationship with the anatomical
extent of disease as expressed by the 6th Edition of the TNM
Classification of Malignant Tumours and the proposals for the 7th
Edition. J Thorac Oncol 2008;3:457–466.
4. Chansky K, Sculier JP, Crowley JJ, et al. The International Association
for the Study of Lung Cancer Staging Project: prognostic factors and
pathological TNM stage in surgically managed non-small cell lung cancer.
J Thorac Oncol 2009;4:792–801.
5. Goldstraw P. History of TNM in Lung Cancer. In: Goldstraw P, ed.
IASLC Staging Manual in Thoracic Oncology . 1st Ed. Florida: EditorialRx,
2009:16–29.
6. Denoix PF. The TNM Staging System. Bull Inst Nat Hyg (Paris) 1952;
7:743.
7. UICC. TNM Classification of Malignant Tumours . 1st Ed. Geneva:
UICC, 1968.
8. Mountain CF, Carr DT, Anderson WA. A system for the clinical staging
of lung cancer. Am J Roentogenol Rad Ther Nucl Med 1974;120:
130–138.
9. UICC. TNM Classification of Malignant Tumours . 2nd Ed. Geneva:
UICC, 1975.
10. American Joint Committee on Cancer Staging and End Results
Reporting. AJC Cancer Staging Manual . 1st Ed. Philadelphia:
Lippincott-Raven, 1977.
11. UICC. TNM Classification of Malignant Tumours . 3rd Ed. Geneva:
UICC, 1978.
12. American Joint Committee on Cancer. Manual for Staging of Cancer.
In: Beahrs OH, Myers MH, eds. 2nd Ed. Philadelphia: JB Lippincott,
1978.
13. Mountain CF. A new international staging system for lung cancer.
Chest 1986;89S:S225–S232.
14. Hermanek P, Sobin LH, UICC. TNM Classification of Malignant
Tumours . 4th Ed. Berlin: Springer Verlag, 1987.
15. American Joint Committee on Cancer. Manual for Staging of
Cancer. In: Beahrs OH, Henson DE, Hutter RVP, et al., eds. 3rd Ed.
Philadelphia: JB Lippincott, 1988.
16. American Joint Committee on Cancer. Manual for Staging of
Cancer. In: Beahrs OH, Henson DE, Hutter RVP, et al., eds. 4th Ed.
Philadelphia: JB Lippincott, 1992.
17. Mountain CF. Revisions in the International System for Staging Lung
Cancer. Chest 1997;111:1710–1717.
18. UICC International Union Against Cancer. TNM Classification of
Malignant Tumours. In: Sobin LH, Wittekind C, eds. 5th Ed. New
York: Wiley-Liss, 1997.
19. American Joint Committee on Cancer. AJCC Cancer Staging
Manual. In: Fleming ID, Cooper JS, Henson DE, et al., eds. 5th Ed.
Philadelphia: Lipincott Raven, 1997.
20. UICC International Union Against Cancer. TNM Classification of
Malignant Tumours . 6th Ed. New York: Wiley-Liss, 2002.
21. American Joint Committee on Cancer. AJCC Cancer Staging Manual .
6th Ed. New York: Springer, 2002.
22. Micke P, Faldum A, Metz T, et al. Staging small cell lung cancer:
Veterans Administration Lung Study Group versus International
Association for the Study of Lung Cancer—what limits limited disease?
Lung Cancer 2002;37:271–276.
23. Goldstraw P. Report on the International workshop on intrathoracic
staging. London, October 1996. Lung Cancer 1997;18:107–111.
24. Goldstraw P, Crowley JJ, Chansky K, et al. The IASLC International
Staging Project on Lung Cancer. J Thorac Oncol 2006;1:281–286.
25. Gospodarowicz MK, Miller D, Groome PA, et al. The process for continuous
improvement of the TNM classification. Cancer 2004;100:1–5.
26. Groome PA, Bolejack V, Crowley JJ, et al. The IASLC Lung Cancer
Staging Project: Validation of the proposals for revision of the T, N, and M
descriptors and consequent stage groupings in the forthcoming (seventh)
TNM classification for lung cancer. J Thorac Oncol 2007;2:694–705.
27. Rami-Porta R, Ball D, Crowley J, et al. The IASLC Lung Cancer
Staging Project: Proposals for the revision of the T descriptors in the
forthcoming (seventh) edition of the TNM classification for lung cancer.
J Thorac Oncol 2007;2:593–602.
28. Rusch VR, Crowley JJ, Giroux DJ, et al. The IASLC Lung Cancer
Staging Project: proposals for revision of the N descriptors in the forthcoming
(seventh) edition of the TNM classification for lung cancer.
J Thorac Oncol 2007;2:603–612.
29. Rusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer
staging project: a proposal for a new international node map in the
forthcoming seventh edition of the TNM classification for lung cancer.
J Thorac Oncol 2009;4:568–577.
30. Postmus PE, Brambilla E, Chansky K, et al. The IASLC Lung Cancer
Staging Project: proposals for revision of the M descriptors in the forthcoming
(seventh) edition of the TNM classification for lung cancer.
J Thorac Oncol 2007;2:686–693.
31. Goldstraw P, Crowley JJ, Chansky K, et al. The IASLC Lung Cancer
Staging Project: proposals for revision of the stage groupings in the
forthcoming (seventh) edition of the TNM classification for lung cancer.
J Thorac Oncol 2007;2:706–714.
32. Crowley JJ, LeBlanc M, Jacobson J, et al. Some exploratory tools for
survival analysis. In: Lin DY, Fleming TR, eds. Proceedings of the First
Seattle Symposium in Biostatistics: Survival analysis . 1st Ed. New York:
Springer, 1997:199–229.
33. Asamura H, Goya T, Koshlishi Y, et al. How should the TNM staging
system for lung cancer be revised? A simulation based on the
Japanese Lung Cancer Registry populations. J Thorac Cardiovasc Surg
2006;132:316–319.
34. O’Quigley J, Xu R. Explained variation in proportional hazards regression.
In: Crowley J, Ankerst D, eds. Handbook of Statistics in Clinical Oncology .
2nd Ed. New York: Chapman and Hall/CRC Press, 2006:347–363.
35. Shepherd FA, Crowley J, Van Houtte P, et al. The IASLC Lung Cancer
Staging Project: proposals regarding the clinical staging of small-cell
lung cancer in the forthcoming (seventh) edition of the TNM classification
for lung cancer. J Thorac Oncol 2007;2:1067–1077.
36. Vallieres E, Shepherd FA, Crowley J, et al. The IASLC Lung Cancer
Staging Project: proposals regarding the relevance of TNM in the pathological
staging of small-cell lung cancer in the forthcoming (seventh)
edition of the TNM classification for lung cancer. J Thorac Oncol 2009;
4:1049–1059.
37. Travis WD, Giroux DJ, Chansky K, et al. The IASLC Lung Cancer
Staging Project: proposals for the inclusion of carcinoid tumours in
the forthcoming (seventh) edition of the TNM classification for lung
cancer. J Thorac Oncol 2008;3:1213–1223.
38. Travis WD, Brambilla E, Rami-Porta R, et al. Visceral pleural invasion:
Pathologic criteria and use of elastic stains: proposals for the
7th edition of the TNM classification for lung cancer. J Thorac Oncol
2008;3:1384–1390.
39. Wittekind C, Greene FL, Henson DE, et al. TNM Supplement: A
Commentary on Uniform Use . 3rd Ed. New Jersey: Wiley-Liss, 2003.
40. Shimizu K, Yoshida J, Nagai K, et al. Visceral pleural invasion classification
in non-small cell lung cancer: a proposal on the basis of outcome
assessment. J Thorac Cardiovasc Surg 2004;127:1574–1578.
41. Berghmans T, Dusart M, Paesmans M, et al. Primary tumour standardized
uptake value (SUVmax) measured on florodeoxyglucose emission
tomography (PDG-PET) is of prognostic value for survival in nonsmall
cell lung cancer (NSCLC): a systematic review and meta-analysis
(MA) by the European Lung Cancer Working Party for the IASLC
Lung Cancer Staging Project. J Thorac Oncol 2008;3:6–12.
42. Goldstraw P. IASLC Staging Handbook in Thoracic Oncology. 1st Ed.
Florida, USA: EditorialRx Press, 2009.
43. Goldstraw P. IASLC Staging Manual in Thoracic Oncology . 1st Ed.
Florida, USA: EditorialRx Press, 2009.
44. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours .
7th Ed. New York: Wiley Liss, 2009.
45. AJCC Cancer Staging Handbook . 7th Ed. New York, Springer, 2009.
46. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac
Cardiovasc Surg 1975;70:606–612.
47. Rami-Porta R, Wittekind C, Goldstraw P. Complete resection in lung
cancer surgery:proposed definition. Lung Cancer 2005;49:25–33.
48. Lim E, Clough R, Goldstraw P, et al. Impact of positive pleural lavage
cytology on survival in patients undergoing lung cancer resection for
non-small cell lung cancer: an International multicentre meta-analysis.
J Thorac Cardiovasc Surg In press 2009.
49. Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant chemotherapy
in stage IB non-small cell lung cancer (NSCLC): update of Cancer
And Leukemia Group B (CALGB) protocol 9633. J Clin Oncol 2006;
24[Abstract 7007], 18s.
50. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung Adjuvant Cisplatin
Evaluation (LACE): a pooled analysis of five randomized clinical
trials including 4,584 patients. J Clin Oncol 2006;24[Abstract
7008], 18s.
51. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus Cisplatin
vs Observation in resected non-small-cell lung cancer. N Engl J Med
2005;352:2589–2597.
52. Douillard JY, Rosell R, Delena M, et al. Adjuvant vinorelbine plus
cisplatin versus observation in patients with completely resected stage
IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International
Trialists Association [ANITA]): a randomised controlled trial. Lancet
Oncol 2006;7:719–727.
53. Giroux DJ, Rami-Porta R, Chansky K, et al. The IASLC Lung Cancer
Staging Project: data elements for the prospective project. J Thorac
Oncol 2009;4:679–683.